- Report
- June 2025
- 400 Pages
Global
From €4466EUR$4,949USD£3,880GBP
- Report
- January 2026
- 160 Pages
Global
From €3030EUR$3,358USD£2,633GBP
€3565EUR$3,950USD£3,097GBP
- Report
- October 2025
- 160 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- August 2025
- 150 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- June 2025
- 127 Pages
Global
From €2662EUR$2,950USD£2,313GBP
- Report
- April 2025
- 93 Pages
Global
From €3500EUR$4,155USD£3,147GBP
- Report
- October 2025
- 162 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- May 2025
- 139 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- February 2026
- 195 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- October 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- September 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- September 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,803GBP
- Report
- September 2025
- 150 Pages
Middle East
From €4467EUR$4,950USD£3,881GBP
- Report
- October 2025
- 125 Pages
United States
From €2301EUR$2,550USD£1,999GBP
- Report
- July 2020
- 323 Pages
Global
From €4421EUR$4,899USD£3,841GBP
- Report
- July 2024
- 119 Pages
Global
From €4196EUR$4,650USD£3,646GBP
- Report
- February 2025
Global
From €4422EUR$4,900USD£3,842GBP
- Report
- January 2025
- 123 Pages
Global
From €3609EUR$3,999USD£3,135GBP
- Report
- September 2024
- 100 Pages
Global
From €5370EUR$5,950USD£4,665GBP

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect.
The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals.
Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more